title: The impact of novel treatment modalities on the therapeutic approach of cardiovascular diseases.
authors.forename: Kosmas I
authors.initials: KI
authors.lastname: Paraskevas
authors.forename: Chrisovalantis
authors.initials: C
authors.lastname: Psathas
authors.forename: Theodoros
authors.initials: T
authors.lastname: Dragios
authors.forename: Dimitrios G
authors.initials: DG
authors.lastname: Chatzis
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: Zenon S
authors.initials: ZS
authors.lastname: Kyriakides
mesh_terms: D043924:Angiogenesis Modulating Agents / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D017690:Cell Transplantation; D003131:Combined Modality Therapy; D003326:Coronary Circulation / Q000187:drug effects; D015316:Genetic Therapy; D006801:Humans; D018919:Neovascularization, Physiologic / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D043924:Angiogenesis Modulating Agents; D002317:Cardiovascular Agents